Layton JE - Search Results

1

Identification of a functional domain of human granulocyte colony-stimulating factor using neutralizing monoclonal antibodies.

Layton JE, Morstyn G, Fabri LJ, Reid GE, Burgess AW, Simpson RJ, Nice EC. Layton JE, et al. J Biol Chem. 1991 Dec 15;266(35):23815-23. J Biol Chem. 1991. PMID: 1721056 Free article.

2

Human granulocyte-macrophage colony-stimulating factor (hGM-CSF): identification of a binding site for a neutralizing antibody.

Nice E, Dempsey P, Layton J, Morstyn G, Cui DF, Simpson R, Fabri L, Burgess A. Nice E, et al. Growth Factors. 1990;3(2):159-69. doi: 10.3109/08977199009108278. Growth Factors. 1990. PMID: 1698402

3

Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity.

Cebon J, Nicola N, Ward M, Gardner I, Dempsey P, Layton J, Dührsen U, Burgess AW, Nice E, Morstyn G. Cebon J, et al. J Biol Chem. 1990 Mar 15;265(8):4483-91. J Biol Chem. 1990. PMID: 2155231 Free article.

4

Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.

Morstyn G, Lieschke GJ, Sheridan W, Layton J, Cebon J, Fox RM. Morstyn G, et al. Semin Hematol. 1989 Apr;26(2 Suppl 2):9-13. Semin Hematol. 1989. PMID: 2471275 Clinical Trial.

5

Mapping of the antibody- and receptor-binding domains of granulocyte colony-stimulating factor using an optical biosensor. Comparison with enzyme-linked immunosorbent assay competition studies.

Nice E, Layton J, Fabri L, Hellman U, Engstrom A, Persson B, Burgess AW. Nice E, et al. J Chromatogr. 1993 Aug 27;646(1):159-68. doi: 10.1016/s0021-9673(99)87017-4. J Chromatogr. 1993. PMID: 7691860

6

Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro.

Dempsey PJ, Layton JE, Duhrsen U, Nicola NA, Cebon J, Burgess AW, Morstyn G. Dempsey PJ, et al. Among authors: layton je. Hybridoma. 1990 Dec;9(6):545-58. doi: 10.1089/hyb.1990.9.545. Hybridoma. 1990. PMID: 1706312

7

Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.

Morstyn G, Sheridan W, Lieschke G, Cebon J, Layton J, Fox R. Morstyn G, et al. Prog Clin Biol Res. 1990;354B:29-36. Prog Clin Biol Res. 1990. PMID: 1700441 Review. No abstract available.

8

Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor.

Layton JE, Hockman H, Sheridan WP, Morstyn G. Layton JE, et al. Blood. 1989 Sep;74(4):1303-7. Blood. 1989. PMID: 2475185 Free article.

9

Early clinical trials with colony-stimulating factors.

Morstyn G, Lieschke GJ, Cebon J, Dührsen U, Villeval JL, Sheridan W, McGrath K, Layton JE. Morstyn G, et al. Among authors: layton je. Cancer Invest. 1989;7(5):443-56. doi: 10.3109/07357908909041375. Cancer Invest. 1989. PMID: 2482790 Review. No abstract available.

10

Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.

Morstyn G, Campbell L, Lieschke G, Layton JE, Maher D, O'Connor M, Green M, Sheridan W, Vincent M, Alton K, et al. Morstyn G, et al. Among authors: layton je. J Clin Oncol. 1989 Oct;7(10):1554-62. doi: 10.1200/JCO.1989.7.10.1554. J Clin Oncol. 1989. PMID: 2789274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters